Literature DB >> 34582313

A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder.

Ashton E Clark1, Shelby R Goodwin1, Russell M Marks2, Annabelle M Belcher1, Emily Heinlein1, Melanie E Bennett1,2, Daniel J O Roche1.   

Abstract

OBJECTIVE: Panic disorder is a debilitating psychiatric disorder that often co-occurs with substance use disorders. Given the current opioid epidemic, the high reported rates of comorbid panic disorder and opioid use disorder are particularly concerning. In this narrative review, we describe the literature on panic disorder and opioid use disorder co-occurrence.
METHODS: 86 studies, 26 reviews, 2 commentaries, and 5 guidelines pertaining to opioid use disorder, panic disorder, and their comorbidity were identified using all EBSCO databases, PubMed, and Google Scholar.
RESULTS: First, we review epidemiological literature on the prevalence of the comorbid condition above and beyond each disorder on its own. Additionally, we discuss the challenges that complicate the differential diagnosis of panic disorder and opioid use disorder and contribute to difficulties establishing rates of comorbidity. Second, we review three theoretical models that have been proposed to explain high rates of co-occurring panic disorder and opioid use disorder: the precipitation hypothesis, the self-medication hypothesis, and the shared vulnerability hypothesis. Third, we outline how co-occurring panic and opioid use disorder may impact treatment for each condition.
CONCLUSION: Based on findings in the field, we provide recommendations for future research as well as treatment considerations for co-occurring panic and opioid use disorders.

Entities:  

Keywords:  Opioid use disorder; addiction; comorbidity; exposure therapy; panic disorder; substance use disorder; treatment

Mesh:

Year:  2021        PMID: 34582313      PMCID: PMC9487392          DOI: 10.1080/15504263.2021.1965407

Source DB:  PubMed          Journal:  J Dual Diagn        ISSN: 1550-4271


  107 in total

1.  Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss.

Authors:  M Preter; S H Lee; E Petkova; M Vannucci; S Kim; D F Klein
Journal:  Psychol Med       Date:  2010-05-06       Impact factor: 7.723

2.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

Authors:  William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

3.  Geographic and specialty distribution of US physicians trained to treat opioid use disorder.

Authors:  Roger A Rosenblatt; C Holly A Andrilla; Mary Catlin; Eric H Larson
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

4.  Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.

Authors:  Ismene L Petrakis; James Poling; Carolyn Levinson; Charla Nich; Kathleen Carroll; Bruce Rounsaville
Journal:  Biol Psychiatry       Date:  2005-05-15       Impact factor: 13.382

5.  Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.

Authors:  R Kathryn McHugh; Victoria R Votaw; David H Barlow; Garrett M Fitzmaurice; Shelly F Greenfield; Roger D Weiss
Journal:  Contemp Clin Trials       Date:  2017-07-08       Impact factor: 2.226

6.  Extended-Release Naltrexone: A Qualitative Analysis of Barriers to Routine Use.

Authors:  Kelly Alanis-Hirsch; Raina Croff; James H Ford; Kim Johnson; Mady Chalk; Laura Schmidt; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2015-11-06

7.  Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling.

Authors:  Lori N Eidson; Kiyoshi Inoue; Larry J Young; Malu G Tansey; Anne Z Murphy
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

8.  Opiorphin causes a panicolytic-like effect in rat panic models mediated by μ-opioid receptors in the dorsal periaqueductal gray.

Authors:  Jhonatan Christian Maraschin; Marcel Pereira Rangel; Antonio Joaquim Bonfim; Mariana Kitayama; Frederico Guilherme Graeff; Hélio Zangrossi; Elisabeth Aparecida Audi
Journal:  Neuropharmacology       Date:  2015-09-10       Impact factor: 5.250

9.  Chronic pain in panic disorder.

Authors:  K Kuch; B J Cox; C B Woszczyna; R P Swinson; I Shulman
Journal:  J Behav Ther Exp Psychiatry       Date:  1991-12

10.  Distance traveled and cross-state commuting to opioid treatment programs in the United States.

Authors:  Andrew Rosenblum; Charles M Cleland; Chunki Fong; Deborah J Kayman; Barbara Tempalski; Mark Parrino
Journal:  J Environ Public Health       Date:  2011-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.